受强制性开放获取政策约束的文章 - Gordan Vujanic了解详情
无法在其他位置公开访问的文章：4 篇
Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion
L de Kock, D Geoffrion, B Rivera, R Wagener, N Sabbaghian, S Bens, ...
Genes, Chromosomes and Cancer 57 (5), 223-230, 2018
强制性开放获取政策： Canadian Institutes of Health Research
Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience
GM Vujanić, N Graf, E D'Hooghe, K Pritchard‐Jones, C Bergeron, ...
Pediatric blood & cancer 71 (3), e30852, 2024
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK, Children’s …
Characteristics and outcome of synchronous bilateral Wilms tumour in the SIOP WT 2001 Study: Report from the SIOP Renal Tumour Study Group (SIOP-RTSG)
H Sudour-Bonnange, H Van Tinteren, GL Ramírez-Villar, J Godzinski, ...
British journal of cancer 131 (6), 972-981, 2024
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK, Children’s …
Predisposition footprints in the somatic genome of Wilms tumours
TD Treger, J Wegert, A Wenger, THH Coorens, R Al-Saadi, PG Kemps, ...
Cancer Discovery, 2024
强制性开放获取政策： National Institute for Health Research, UK, Wellcome Trust
可在其他位置公开访问的文章：57 篇
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome
I Slade, C Bacchelli, H Davies, A Murray, F Abbaszadeh, S Hanks, ...
Journal of medical genetics 48 (4), 273-278, 2011
强制性开放获取政策： Cancer Research UK
Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol
MM Van Den Heuvel-eibrink, JA Hol, K Pritchard-Jones, H Van Tinteren, ...
Nature Reviews Urology 14 (12), 743-752, 2017
强制性开放获取政策： Cancer Research UK
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
GM Vujanić, M Gessler, AHAG Ooms, P Collini, A Coulomb-l’Hermine, ...
Nature Reviews Urology 15 (11), 693-701, 2018
强制性开放获取政策： Cancer Research UK
Omission of doxorubicin from the treatment of stage II–III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial
K Pritchard-Jones, C Bergeron, B De Camargo, ...
The Lancet 386 (9999), 1156-1164, 2015
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Wilms tumour
F Spreafico, CV Fernandez, J Brok, K Nakata, G Vujanic, JI Geller, ...
Nature Reviews Disease Primers 7 (1), 75, 2021
强制性开放获取政策： Cancer Research UK
Gain of 1q as a prognostic biomarker in Wilms tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: a …
T Chagtai, C Zill, L Dainese, J Wegert, S Savola, S Popov, W Mifsud, ...
Journal of Clinical Oncology 34 (26), 3195-3203, 2016
强制性开放获取政策： German Research Foundation, National Institute of Health and Medical …
Stratification of Wilms tumor by genetic and epigenetic analysis
RH Scott, A Murray, L Baskcomb, C Turnbull, C Loveday, R Al-Saadi, ...
Oncotarget 3 (3), 327, 2012
强制性开放获取政策： Cancer Research UK
Multiple mechanisms of MYCN dysregulation in Wilms tumour
RD Williams, T Chagtai, M Alcaide-German, J Apps, J Wegert, S Popov, ...
Oncotarget 6 (9), 7232, 2015
强制性开放获取政策： German Research Foundation, Cancer Research UK, National Institute for …
Congenital mesoblastic nephroma 50 years after its recognition: a narrative review
SL Gooskens, ME Houwing, GM Vujanic, JS Dome, T Diertens, ...
Pediatric blood & cancer 64 (7), e26437, 2017
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
TP53 mutational status is a potential marker for risk stratification in Wilms tumour with diffuse anaplasia
M Maschietto, RD Williams, T Chagtai, SD Popov, NJ Sebire, G Vujanic, ...
PloS one 9 (10), e109924, 2014
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, National Institute for …
Subtype-Specific FBXW7 Mutation and MYCN Copy Number Gain in Wilms' Tumor
RD Williams, R Al-Saadi, T Chagtai, S Popov, B Messahel, N Sebire, ...
Clinical Cancer Research 16 (7), 2036-2045, 2010
强制性开放获取政策： Cancer Research UK
Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group …
MM Van den Heuvel-Eibrink, H Van Tinteren, C Bergeron, ...
European journal of cancer 51 (4), 498-506, 2015
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Anaplastic sarcomas of the kidney are characterized by DICER1 mutations
MK Wu, GM Vujanic, S Fahiminiya, N Watanabe, PS Thorner, ...
Modern Pathology 31 (1), 169-178, 2018
强制性开放获取政策： Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1–3 clinical trials: A Children’s Cancer and Leukaemia Group (CCLG) study
B Messahel, R Williams, A Ridolfi, R A’Hern, W Warren, L Tinworth, ...
European Journal of Cancer 45 (5), 819-826, 2009
强制性开放获取政策： Cancer Research UK
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy–the United Kingdom experience
S Irtan, M Jitlal, J Bate, M Powis, G Vujanic, A Kelsey, J Walker, C Mitchell, ...
European Journal of Cancer 51 (2), 225-232, 2015
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
J Charlton, RD Williams, NJ Sebire, S Popov, G Vujanic, T Chagtai, ...
Genome medicine 7, 1-11, 2015
强制性开放获取政策： Cancer Research UK, UK Medical Research Council, National Institute for …
出版信息和资助信息由计算机程序自动确定